Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study

Ellen Ritchiea Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY, USACorrespondence[email protected]

Craig Kesslerc Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USAView further author information

Robyn Scherberd Incyte Corporation, Wilmington, DE, USA;e UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USAView further author information

Haobo Rend Incyte Corporation, Wilmington, DE, USAView further author information

Ruben Mesae UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USA

Your download is now in progress and you may close this window